These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 2552825)
1. Vasoactive intestinal peptide and its receptors in fetuses with cystic fibrosis. Chastre E; Bawab W; Faure C; Emami S; Muller F; Boué A; Gespach C Am J Physiol; 1989 Oct; 257(4 Pt 1):G561-9. PubMed ID: 2552825 [TBL] [Abstract][Full Text] [Related]
2. Ontogenic development of vasoactive intestinal peptide receptors in rat intestinal cells and liver. Chastre E; Emami S; Rosselin G; Gespach C Endocrinology; 1987 Dec; 121(6):2211-21. PubMed ID: 2824182 [TBL] [Abstract][Full Text] [Related]
3. Characterization of binding sites for VIP-related peptides and activation of adenylate cyclase in developing pancreas. Le Meuth V; Farjaudon N; Bawab W; Chastre E; Rosselin G; Guilloteau P; Gespach C Am J Physiol; 1991 Feb; 260(2 Pt 1):G265-74. PubMed ID: 1847591 [TBL] [Abstract][Full Text] [Related]
4. Pharmacology, molecular identification and functional characteristics of vasoactive intestinal peptide receptors in human breast cancer cells. Gespach C; Bawab W; de Cremoux P; Calvo F Cancer Res; 1988 Sep; 48(18):5079-83. PubMed ID: 2842044 [TBL] [Abstract][Full Text] [Related]
5. Distribution of vasoactive intestinal polypeptide and substance P receptors in human colon and small intestine. Korman LY; Sayadi H; Bass B; Moody TW; Harmon JW Dig Dis Sci; 1989 Jul; 34(7):1100-8. PubMed ID: 2472937 [TBL] [Abstract][Full Text] [Related]
6. Distribution of vasoactive intestinal polypeptide (VIP) binding in circular muscle and characterization of VIP binding in canine small intestinal mucosa. Mao YK; Barnett W; Coy DH; Tougas G; Daniel EE J Pharmacol Exp Ther; 1991 Sep; 258(3):986-91. PubMed ID: 1653848 [TBL] [Abstract][Full Text] [Related]
7. Effect of freezing on the coupling of VIP receptors to adenylate cyclase in rat liver membranes. Robberecht P; Waelbroeck M; De Neef P; Camus JC; Gourlet P; Christophe J Life Sci; 1988; 42(5):505-10. PubMed ID: 2828794 [TBL] [Abstract][Full Text] [Related]
8. Ac-Tyr1hGRF discriminates between VIP receptors from rat liver and intestinal epithelium. Rouyer-Fessard C; Couvineau A; Voisin T; Laburthe M Life Sci; 1989; 45(9):829-33. PubMed ID: 2549322 [TBL] [Abstract][Full Text] [Related]
9. Characterization of a common VIP-PACAP receptor in human small intestinal epithelium. Salomon R; Couvineau A; Rouyer-Fessard C; Voisin T; Lavallée D; Blais A; Darmoul D; Laburthe M Am J Physiol; 1993 Feb; 264(2 Pt 1):E294-300. PubMed ID: 8383439 [TBL] [Abstract][Full Text] [Related]
11. HT 29, a model cell line: stimulation by the vasoactive intestinal peptide (VIP); VIP receptor structure and metabolism. Marchis-Mouren G; Martin JM; Luis J; el Battari A; Muller JM; Marvaldi J; Pichon J Biochimie; 1988 May; 70(5):663-71. PubMed ID: 2844304 [TBL] [Abstract][Full Text] [Related]
12. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in turkey cerebral cortex: characterization by [125I]-VIP binding and effects on cyclic AMP synthesis. Zawilska JB; Niewiadomski P; Nowak JZ Gen Comp Endocrinol; 2004 Jun; 137(2):187-95. PubMed ID: 15158130 [TBL] [Abstract][Full Text] [Related]
13. Autoradiographic localization of binding sites for galanin and VIP in small intestine. King SC; Slater P; Turnberg LA Peptides; 1989; 10(2):313-7. PubMed ID: 2474152 [TBL] [Abstract][Full Text] [Related]
14. Vasoactive intestinal peptide and intraocular pressure: adenylate cyclase activation and binding sites for vasoactive intestinal peptide in membranes of ocular ciliary processes. Mittag TW; Tormay A; Podos SM J Pharmacol Exp Ther; 1987 Apr; 241(1):230-5. PubMed ID: 3033201 [TBL] [Abstract][Full Text] [Related]
15. Selective photolabeling of high and low affinity binding sites for vasoactive intestinal peptide (VIP): evidence for two classes of covalent VIP-receptor complexes in intestinal cell membranes. Robichon A; Marie JC Endocrinology; 1987 Mar; 120(3):978-85. PubMed ID: 3026793 [TBL] [Abstract][Full Text] [Related]
16. Homologous regulation of adenylate cyclase-coupled receptors for vasoactive intestinal peptide (VIP) on human mononuclear leucocytes. Wiik P Regul Pept; 1988 Apr; 20(4):323-33. PubMed ID: 2835796 [TBL] [Abstract][Full Text] [Related]
18. Autoradiographic localization of vasoactive intestinal peptide (VIP) binding sites in the human term placenta. Relationship with activation of adenylate cyclase. Besson J; Malassiné A; Ferré F Regul Pept; 1987 Nov; 19(3-4):197-207. PubMed ID: 2829291 [TBL] [Abstract][Full Text] [Related]
19. Effector mechanisms of peptides of the VIP family. Christophe J; Svoboda M; Lambert M; Waelbroeck M; Winand J; Dehaye JP; Vandermeers-Piret MC; Vandermeers A; Robberecht P Peptides; 1986; 7 Suppl 1():101-7. PubMed ID: 3018687 [TBL] [Abstract][Full Text] [Related]